IP Group PLC
08 January 2007
For immediate release 8 January 2007
IP Group plc
PERACHEM TO JOIN PLUS MARKETS GROUP VIA REVERSE TAKEOVER OF PRIMAVERA
IP Group plc (LSE: IPO) ('IP Group'), the intellectual property
commercialisation company, is pleased to note that Perachem Ltd ('Perachem'), a
speciality chemicals company held within the IP Group portfolio and a spin-out
company from the University of Leeds, is to join PLUS Markets Group ('PLUS
Markets') via a reverse takeover of Primavera Capital plc (PLUS: PRCO)
('Primavera').
On completion of the transaction, IP Group's holding in Primavera will total
1,950,545 Ordinary Shares (worth £1.1 million at the placing price of 55p per
share), representing 24.5% of the enlarged share capital.
Primavera has announced today that it has agreed, subject, inter alia, to
existing shareholder approval, to issue 5,407,272 new Ordinary Shares in
consideration for the entire issued and to be issued share capital of Perachem.
Primavera has also proposed to raise £250,000 (before expenses) by means of a
placing of 454,545 new Ordinary Shares at 55p per share. These funds will be
used to finance the development of Perachem and provide additional working
capital for the enlarged group. On completion of the transaction, Primavera has
proposed that it change its name to Eco Chemical Enterprises plc.
Perachem's business is focussed on developing the following products:
(i) chlorine-free shrink resistant treatments for wool;
(ii) flame retardant textiles that do not release potentially carcinogenic
halogens and formaldehyde during their manufacture or use;
(iii) peroxide-free bleaching agents; and
(iv) textiles with long lasting microbial protection against antibiotic
resistant bacteria.
The acquisition of Primavera is classified as a reverse takeover under the PLUS
Markets Rules by virtue of its size and is conditional, inter alia, on the
approval of Primavera shareholders.
For further information, please contact:
IP Group plc 020 7489 5200
Alan Aubrey, Chief Executive Officer
Liz Vaughan-Adams (communications) 0207 4895206/07979 853802
Buchanan Communications 020 7466 5000
Tim Anderson, Mark Court, Mary-Jane Johnson
Notes for Editors
About IP Group
IP Group Plc is an intellectual property (IP) commercialisation company that
specialises in commercialising university technology. Founded in 2001, IP Group
listed on AiM in October 2003 and moved to the Official List in June 2006. It
has made two acquisitions to date - Techtran, a company set up to commercialise
university intellectual property under a long term contract with the University
of Leeds, in 2005 and Top Technology Ventures, an investment adviser to early
stage technology venture capital funds, in 2004.
The group has formed long-term partnerships with ten universities - the
University of Oxford, King's College London, CNAP/University of York, the
University of Leeds, the University of Bristol, the University of Surrey, the
University of Southampton, Queen Mary (University of London), the University of
Bath and the University of Glasgow.
As at 30 June 2006, 44 spin-out companies had been created among the group's
university partners. Of those, eight have listed on the AiM market of the London
Stock Exchange and there have been two trade sales.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
This information is provided by RNS
The company news service from the London Stock Exchange
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.